BENEDETTI, Rosaria
 Distribuzione geografica
Continente #
NA - Nord America 2.773
EU - Europa 2.490
AS - Asia 1.772
SA - Sud America 391
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.446
Nazione #
US - Stati Uniti d'America 2.728
RU - Federazione Russa 1.049
SG - Singapore 613
IT - Italia 451
IE - Irlanda 425
CN - Cina 413
BR - Brasile 326
HK - Hong Kong 282
VN - Vietnam 136
KR - Corea 128
DE - Germania 123
GB - Regno Unito 108
UA - Ucraina 92
IN - India 69
FI - Finlandia 47
AR - Argentina 35
FR - Francia 29
SE - Svezia 29
GR - Grecia 26
JP - Giappone 26
NL - Olanda 24
TR - Turchia 23
CA - Canada 19
MX - Messico 19
PK - Pakistan 17
AT - Austria 16
EC - Ecuador 14
DK - Danimarca 12
HU - Ungheria 12
ES - Italia 11
BD - Bangladesh 9
ID - Indonesia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
IQ - Iraq 6
PL - Polonia 6
UZ - Uzbekistan 6
IL - Israele 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CO - Colombia 4
KE - Kenya 4
MA - Marocco 4
PT - Portogallo 4
TW - Taiwan 4
VE - Venezuela 4
LK - Sri Lanka 3
LT - Lituania 3
NP - Nepal 3
ZA - Sudafrica 3
AL - Albania 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
IM - Isola di Man 2
KZ - Kazakistan 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.446
Città #
Chicago 535
Wilmington 433
Dublin 423
Moscow 360
Falls Church 334
Singapore 301
Hong Kong 282
Santa Clara 259
Chandler 193
Jacksonville 135
Seoul 126
Hefei 93
Naples 85
Beijing 80
Ashburn 66
Bengaluru 54
New York 49
Caserta 47
Princeton 44
Ho Chi Minh City 42
Munich 37
Roxbury 37
Boardman 35
Dallas 34
The Dalles 34
Medford 29
Dong Ket 26
São Paulo 26
Aversa 24
Hanoi 23
Los Angeles 21
Ann Arbor 16
Milan 16
Cambridge 15
Napoli 14
Stuttgart 14
Bremen 13
Houston 12
Nuremberg 12
Rio de Janeiro 12
Rome 12
Buenos Aires 11
Vienna 11
Belo Horizonte 10
Copenhagen 10
Des Moines 10
San Mateo 10
Curitiba 8
Helsinki 8
London 8
Mountain View 8
San Giuseppe Vesuviano 8
Turku 8
Afragola 7
Amsterdam 7
Brooklyn 7
Cicciano 7
Lappeenranta 7
Mexico City 7
Quito 7
Woodbridge 7
Boston 6
Brussels 6
Groningen 6
Guangzhou 6
Jakarta 6
Montreal 6
Porto Alegre 6
Salvador 6
Shanghai 6
Tashkent 6
Tianjin 6
Viterbo 6
Warsaw 6
Boydton 5
Brasília 5
Chennai 5
Columbus 5
Florence 5
Haiphong 5
Nanjing 5
Recife 5
San Francisco 5
Seattle 5
Vico Equense 5
Airola 4
Bacoli 4
Barcelona 4
Cascina 4
Casoria 4
Charlotte 4
Ercolano 4
Falkenstein 4
Frankfurt am Main 4
Istanbul 4
Lisbon 4
Ludwigsburg 4
Madrid 4
Magdeburg 4
Menlo Park 4
Totale 4.762
Nome #
Epigenetic mechanisms underlying prostate cancer radioresistance 1.378
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 142
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 121
HIF3A inhibition triggers browning of white adipocytes via metabolic rewiring. 118
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma 117
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 117
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 116
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 116
Deregulation of new cell death mechanisms in Leukemia 111
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 111
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 109
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients:a meta-analysis of randomized clinical trials 108
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine Specific Demethylases Display High Anticancer Activities. 105
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 104
Breast Cancer Vaccines: New Insights 103
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 99
Epigenetic-based therapy: From single- to multi-target approaches 99
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 98
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 95
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics 94
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 91
EPIGENETIC-BASED DRUGS IN STEM CELL DIFFERENTIATION 91
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 91
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer 90
Involvement of regulated cell deaths in aging and age-related pathologies 88
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 88
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 88
HDAC6 inhibition extinguishes autophagy in cancer: Recent insights 88
HAT1: Landscape of Biological Function and Role in Cancer 87
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 86
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 86
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification 85
Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives 85
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells. 85
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 84
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 83
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity 83
I BET on anti-FGFR to fight cancer resistance 82
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy 82
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: Evidence in human cardiomyocyte cell line 78
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma 78
Whole-Genome Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic Stem Cells. 78
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer 77
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research 77
Design and Synthesis of New Oligopeptidic Parvulin Inhibitors 77
Targeting HDACs in diseases: where are we? 76
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game? 75
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment 73
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 73
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90 73
DNA Mutations via Chern-Simons Currents 73
Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome 72
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 71
EPIGENETIC MODULATION OF LAT1 EXPRESSION TO ENHANCE OSTEOSARCOMA SENSITIVITY TO BORON NEUTRON CAPTURE THERAPY (BNCT) 70
Modulation of Autophagy and Apoptosis in Leukemia 69
New Anacardic Acid-Inspired Benzamides: Histone Lysine Acetyltransferase Activators 68
Trials with 'epigenetic' drugs: An update. 68
Harnessing normalcy: The potential of healthy tissuefor patient outcomes 65
The role of SAHA in boron uptake: harnessing epigenetic regulation of LAT1 for optimized BNCT 64
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia- exposed human cardiomyocytes through comprehensive multi-level analysis 64
Structure-Activity Relationships on Cynnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase 64
Unravelling the impact of the chromobox proteins in human cancers 63
Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs) 63
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 61
The innovative potential of selenium-containing agents for fighting cancer and viral infections 61
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 60
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes 60
Role of Ferroptosis in AML Pathophysiology and Therapeutic Strategies 59
Psidium guajava L. anti-neoplastic effects: induction of apoptosis and cell differentiation. 59
Current Preclinical Applications of Pharmaco-Epigenetics in Cardiovascular Diseases 56
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors 55
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 49
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 49
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 49
“Aging and epigenetic implications in radiotherapy: The promise of BNCT” 41
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis 41
Phase separation rewires chromatin in breast cancer 40
In-Depth Exploration of Radiation-Induced Cell Death Mechanisms in Tumor 35
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 23
Totale 7.611
Categoria #
all - tutte 26.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 2 35 23 10 22 31 37
2021/20221.169 80 137 253 95 163 42 40 31 27 81 62 158
2022/20231.271 143 110 339 57 68 49 5 41 415 10 13 21
2023/2024442 30 13 16 21 88 65 16 34 11 31 36 81
2024/20251.465 15 39 46 70 206 158 253 133 165 118 128 134
2025/20262.640 306 355 358 323 515 783 0 0 0 0 0 0
Totale 7.611